{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:47:09Z","timestamp":1793011629354,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018592","name":"\u201c333 Project\u201d of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The molecules of the complement system connect the effectors of innate and adaptive immunity and play critical roles in maintaining homeostasis. Among them, the C1 complex, composed of C1q, C1r, and C1s (C1qr\n                    <jats:sub>2<\/jats:sub>\n                    s\n                    <jats:sub>2<\/jats:sub>\n                    ), is the initiator of the classical complement activation pathway. While deficiency of C1s is associated with early-onset systemic lupus erythematosus and increased susceptibility to bacteria infections, the gain-of- function variants of C1r and C1s may lead to periodontal Ehlers Danlos syndrome. As C1s is activated under various pathological conditions and associated with inflammation, autoimmunity, and cancer development, it is becoming an informative biomarker for the diagnosis and treatment of a variety of diseases. Thus, more sensitive and convenient methods for assessing the level as well as activity of C1s in clinic samples are highly desirable. Meanwhile, a number of small molecules, peptides, and monoclonal antibodies targeting C1s have been developed. Some of them are being evaluated in clinical trials and one of the antibodies has been approved by US FDA for the treatment of cold agglutinin disease, an autoimmune hemolytic anemia. In this review, we will summarize the biological properties of C1s, its association with development and diagnosis of diseases, and recent progress in developing drugs targeting C1s. These progress illustrate that the C1s molecule is an effective biomarker and promising drug target.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.1015128","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T09:03:07Z","timestamp":1665046987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Complement C1s as a diagnostic marker and therapeutic target: Progress and propective"],"prefix":"10.3389","volume":"13","author":[{"given":"Jun","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19-Related systemic thrombosis","volume":"22","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.04.002","article-title":"Complement activation and inhibition in autoimmune hemolytic anemia: Focus on cold agglutinin disease","volume":"55","author":"Berentsen","year":"2018","journal-title":"Semin Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-014-8453-8","article-title":"Vasculitides and the complement system: a comprehensive review","volume":"49","author":"Chimenti","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.05.001","article-title":"Complement deficiency states and associated infections","volume":"48","author":"Skattum","year":"2011","journal-title":"Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are complement deficiencies really rare? overview on prevalence, clinical importance and modern diagnostic approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2016.06.001","article-title":"Overview of laboratory testing and clinical presentations of complement deficiencies and dysregulation","volume":"77","author":"Frazer-Abel","year":"2016","journal-title":"Adv Clin Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00565","article-title":"Deciphering the fine details of c1 assembly and activation mechanisms: \"mission impossible\"","volume":"5","author":"Gaboriaud","year":"2014","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imbio.2009.08.006","article-title":"Paths reunited: Initiation of the classical and lectin pathways of complement activation","volume":"215","author":"Wallis","year":"2010","journal-title":"Immunobiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1182\/blood-2018-06-856930","article-title":"Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial","volume":"133","author":"Jager","year":"2019","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027760","article-title":"Sutimlimab in cold agglutinin disease","volume":"384","author":"Roth","year":"2021","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800998","article-title":"C1s inhibition by BIVV009 (Sutimlimab) prevents complement-enhanced activation of autoimmune human b cells In vitro","volume":"202","author":"Nikitin","year":"2019","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13648","article-title":"Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor","volume":"173","author":"Peerschke","year":"2016","journal-title":"Br J Haematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/bi00400a004","article-title":"Complete cDNA sequence of human complement cls and close physical linkage of the homologous genes cls and clr","volume":"26","author":"Tosi","year":"1987","journal-title":"Biochemistry-US"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/BF00291737","article-title":"Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13","volume":"78","author":"Nguyen","year":"1988","journal-title":"Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(90)90169-G","article-title":"Proteolysis of the heavy chain of major histocompatibility complex class I antigens by complement component C1s","volume":"1037","author":"Eriksson","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15505.x","article-title":"Limited proteolysis of beta 2-microglobulin at lys-58 by complement component C1s","volume":"189","author":"Nissen","year":"1990","journal-title":"Eur J Biochem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006107200","article-title":"The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium","volume":"275","author":"Busby","year":"2000","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.047","article-title":"Complement C1q activates canonical wnt signaling and promotes aging-related phenotypes","volume":"149","author":"Naito","year":"2012","journal-title":"CELL"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913449107","article-title":"Enhanced synaptic connectivity and epilepsy in C1q knockout mice","volume":"107","author":"Chu","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.670661","article-title":"C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins","volume":"290","author":"Cai","year":"2015","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/cddiscovery.2016.69","article-title":"Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis","volume":"2","author":"Yeo","year":"2016","journal-title":"Cell Death Discovery"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-018-0020-5","article-title":"C1r\/C1s deficiency is insufficient to induce murine systemic lupus erythematosus","volume":"20","author":"Uchio-Yamada","year":"2019","journal-title":"Genes Immun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.09.034","article-title":"Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s gene","volume":"45","author":"Amano","year":"2008","journal-title":"Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7612","article-title":"Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases","volume":"166","author":"Dragon-Durey","year":"2001","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050843","article-title":"Selective complement C1s deficiency caused by homozygous four-base deletion in the C1s gene","volume":"103","author":"Inoue","year":"1998","journal-title":"Hum Genet"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.4.2180","article-title":"Molecular basis of human complement C1s deficiency","volume":"162","author":"Endo","year":"1999","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.3.1681","article-title":"Unique phenotypes of C1s deficiency and abnormality caused by two compound heterozygosities in a Japanese family","volume":"182","author":"Abe","year":"2009","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.08.019","article-title":"Periodontal ehlers-danlos syndrome is caused by mutations in C1R and C1S, which encode subcomponents C1r and C1s of complement","volume":"99","author":"Kapferer-Seebacher","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13972","article-title":"Periodontal (formerly type VIII) ehlers-danlos syndrome: Description of 13 novel cases and expansion of the clinical phenotype","volume":"100","author":"El","year":"2021","journal-title":"Clin Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02962","article-title":"Two different missense C1S mutations, associated to periodontal ehlers-danlos syndrome, lead to identical molecular outcomes","volume":"10","author":"Bally","year":"2019","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718709115","article-title":"Structure of the C1r-C1s interaction of the C1 complex of complement activation","volume":"115","author":"Almitairi","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1056\/NEJMoa1615887","article-title":"CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis","volume":"377","author":"Ozen","year":"2017","journal-title":"N Engl J Med"},{"key":"B36","first-page":"35","article-title":"Cold agglutinin disease: where do we stand, and where are we going","volume":"18","author":"Berentsen","year":"2020","journal-title":"Clin Adv Hematol Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2991\/chi.k.200706.001","article-title":"Cold agglutinin disease","volume":"2","author":"Gabbard","year":"2020","journal-title":"Clin Hematol Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"153165097","DOI":"10.1177\/2040620719873321","article-title":"Novel insights into the treatment of complement-mediated hemolytic anemias","volume":"10","author":"Berentsen","year":"2019","journal-title":"Ther Adv Hematol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1884223","article-title":"Targeting the complement system in neuromyelitis optica spectrum disorder","volume":"21","author":"Asavapanumas","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00568-8","article-title":"Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials","volume":"17","author":"Pittock","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.3.175","article-title":"Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody","volume":"58","author":"Nakagawa","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.131.4.803","article-title":"Deficiency of C1r in human serum. effects on the structure and function of macromolecular C1","volume":"131","author":"Pickering","year":"1970","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197203302861304","article-title":"Lupus-erythematosus-like syndrome with a familial defect of complement","volume":"286","author":"Moncada","year":"1972","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106902","article-title":"C1r deficiency: an inborn error associated with cutaneous and renal disease","volume":"51","author":"Day","year":"1972","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13962","article-title":"EDTA\/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosus","volume":"23","author":"Ugarte-Berzal","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.9.4641","article-title":"In vitro stimulation of C1s proteolytic activities by C1s-presenting autoantibodies from patients with systemic lupus erythematosus","volume":"160","author":"He","year":"1998","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.3390\/ijms23169281","article-title":"Autoantibodies against complement classical pathway components C1q, C1r, C1s and C1-inh in patients with lupus nephritis","volume":"23","author":"Radanova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.761395","article-title":"Epitope-specific anti-C1q autoantibodies in systemic lupus erythematosus","volume":"12","author":"Kleer","year":"2021","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02619","article-title":"Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein-Barr virus-derived antigenic site","volume":"10","author":"Csorba","year":"2019","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005361","article-title":"Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18095","article-title":"Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma","volume":"182","author":"Riihila","year":"2020","journal-title":"Br J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S334041","article-title":"Development of an interferon gamma response-related signature for prediction of survival in clear cell renal cell carcinoma","volume":"14","author":"Liu","year":"2021","journal-title":"J Inflammation Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-20-0532","article-title":"Complement C1s and C4d as prognostic biomarkers in renal cancer: Emergence of noncanonical functions of C1s","volume":"9","author":"Daugan","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302031","article-title":"Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells","volume":"192","author":"Ghebrehiwet","year":"2014","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0891","article-title":"Tumor cells hijack macrophage-produced complement C1q to promote tumor growth","volume":"7","author":"Roumenina","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1159\/000491439","article-title":"Complement and bacterial infections: From molecular mechanisms to therapeutic applications","volume":"10","author":"Heesterbeek","year":"2018","journal-title":"J Innate Immun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.701362","article-title":"Interactions between pathogenic burkholderia and the complement system: A review of potential immune evasion mechanisms","volume":"11","author":"Syed","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1977.tb03604.x","article-title":"C1 subcomponents in acute pneumococcal otitis media in children","volume":"85","author":"Johnson","year":"1977","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"B59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","article-title":"Ultra-High-Throughput clinical proteomics reveals classifiers of COVID-19 infection","volume":"11","author":"Messner","year":"2020","journal-title":"Cell Syst"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13337-021-00710-6","article-title":"Patients with covid 19 have significantly reduced CH50 activity","volume":"32","author":"Keshavarz","year":"2021","journal-title":"Virusdisease"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.767981","article-title":"SARS-CoV-2 antibodies mediate complement and cellular driven inflammation","volume":"12","author":"Jarlhelt","year":"2020","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838780","article-title":"SARS-CoV-2 spike- and nucleoprotein-specific antibodies induced after vaccination or infection promote classical complement activation","volume":"13","author":"Lamerton","year":"2022","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02072","article-title":"Treatment of COVID-19 with conestat Alfa, a regulator of the complement, contact activation and kallikrein-kinin system","volume":"11","author":"Urwyler","year":"2020","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00406","article-title":"Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential","volume":"5","author":"Sharp","year":"2014","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.01.064","article-title":"Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s","volume":"18","author":"Travins","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"B66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/biom8020024","article-title":"Pharmaceutical machine learning: Virtual high-throughput screens identifying promising and economical small molecule inhibitors of complement factor C1s","volume":"8","author":"Chen","year":"2018","journal-title":"Biomolecules"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24203641","article-title":"Design and selection of novel C1s inhibitors by in silico and in vitro approaches","volume":"24","author":"Szilagyi","year":"2019","journal-title":"Molecules"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210804085636","article-title":"C1-inhibitor: Structure, functional diversity and therapeutic development","volume":"29","author":"Karnaukhova","year":"2022","journal-title":"Curr Med Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2004.17.7.863703","article-title":"Biological effects of C1 inhibitor","volume":"17","author":"Davis","year":"2004","journal-title":"Drug News Perspect"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S9576","article-title":"Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety","volume":"1","author":"Lunn","year":"2010","journal-title":"J Blood Med"},{"key":"B71","unstructured":"ClinicalTrials.gov2021"},{"key":"B72","unstructured":"ClinicalTrials.gov2021"},{"key":"B73","unstructured":"ClinicalTrials.gov2021"},{"key":"B74","unstructured":"ClinicalTrials.gov2021"},{"key":"B75","unstructured":"ClinicalTrials.gov2021"},{"key":"B76","unstructured":"ClinicalTrials.gov2021"},{"key":"B77","unstructured":"ClinicalTrials.gov2021"},{"key":"B78","unstructured":"ClinicalTrials.gov2021"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012860","article-title":"Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond","volume":"139","author":"Gavriilaki","year":"2022","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.026","article-title":"Increasing the complement of therapeutic options in bullous pemphigoid","volume":"138","author":"Kushner","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.08.030","article-title":"The anti-C1s antibody TNT003 prevents complement activation in the skin induced by bullous pemphigoid autoantibodies","volume":"138","author":"Kasprick","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13273","article-title":"An anti-C1s monoclonal, TNT003, inhibits complement activation induced by antibodies against HLA","volume":"15","author":"Thomas","year":"2015","journal-title":"Am J Transplant"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001486","article-title":"Complement-mediated enhancement of monocyte adhesion to endothelial cells by HLA antibodies, and blockade by a specific inhibitor of the classical complement cascade, TNT003","volume":"101","author":"Valenzuela","year":"2017","journal-title":"Transplantation"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001804","article-title":"Blockade of HLA antibody-triggered classical complement activation in sera from subjects dosed with the anti-C1s monoclonal antibody TNT009-results from a randomized first-in-Human phase 1 trial","volume":"101","author":"Muhlbacher","year":"2017","journal-title":"Transplantation"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1900031","article-title":"Effect of a C1s inhibitor on the efficacy of anti-capsular antibodies against neisseria meningitidis and streptococcus pneumoniae","volume":"3","author":"Lewis","year":"2019","journal-title":"Immunohorizons"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01711-5","article-title":"Sutimlimab: First approval","volume":"82","author":"Dhillon","year":"2022","journal-title":"Drugs"},{"key":"B87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-62703-724-2_2","article-title":"Evaluation of complement function by ELISA","volume":"1100","author":"Roos","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J Immunol Methods"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101749","article-title":"Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance","volume":"187","author":"Roumenina","year":"2011","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.06.150","article-title":"Complement analysis in the 21st century","volume":"44","author":"Mollnes","year":"2007","journal-title":"Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221076733","article-title":"Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel","volume":"31","author":"Dasdemir","year":"2022","journal-title":"Lupus"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.147.2.385","article-title":"Demonstration and quantitation of activation of the first component of complement in human serum","volume":"147","author":"Ziccardi","year":"1978","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061180","article-title":"Aqueous humor proteomic alterations associated with visual field index parameters in glaucoma patients: A pilot study","volume":"10","author":"Kodeboyina","year":"2021","journal-title":"J Clin Med"},{"key":"B94","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.142.8.2743","article-title":"Probing the C4-binding site on C1s with monoclonal antibodies. evidence for a C4\/C4b-binding site on the gamma-domain","volume":"142","author":"Matsumoto","year":"1989","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.43.30468","article-title":"The human cytotoxic T cell granule serine protease granzyme h has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme b-containing endosomes","volume":"274","author":"Edwards","year":"1999","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.3.175","article-title":"Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody","volume":"58","author":"Nakagawa","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1983.tb07100.x","article-title":"Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s","volume":"129","author":"Nilsson","year":"1983","journal-title":"Eur J Biochem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/diagnostics11061079","article-title":"Identification of diagnostic biomarkers and their correlation with immune infiltration in age-related macular degeneration","volume":"11","author":"Zeng","year":"2021","journal-title":"Diagnostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1015128\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:58:42Z","timestamp":1677027522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1015128\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2022.1015128"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1015128","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"1015128"}}